RULE NO.:RULE TITLE:
64B15-14.004Standards for the Prescription of Obesity Drugs
PURPOSE AND EFFECT: The purpose of the rule development is to update the rule language.
SUBJECT AREA TO BE ADDRESSED: The rule language.
RULEMAKING AUTHORITY: 459.005, 459.0135 FS.
LAW IMPLEMENTED: 459.0135 FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: IS: Kama Monroe, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256, or by email at Kama.Monroe@flhealth.gov.
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.
Document Information
- Purpose:
- The purpose of the rule development is to update the rule language.
- Rulemaking Authority:
- 459.005, 459.0135 FS.
- Law:
- 459.0135 FS.
- Related Rules: (1)
- 64B15-14.004. Standards for the Prescription of Obesity Drugs